The role of radiotherapy and the value of combined treatment in lung cancer

European Journal of Cancer

Volumn 37, Issue SUPPL. 7, 2001, Pages

  Van Houtte, Paul ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; RADIATION DOSE FRACTIONATION; REVIEW; SMALL CELL CARCINOMA;

BRACHYTHERAPY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; PALLIATIVE CARE; RADIOTHERAPY, CONFORMAL;

EID: 0035496612     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. PORT. Meta-analysis Trialists Group Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998, 352: 257-263.
2. Stewart LA, Pignon JP. (Non-small Cell Cancer Collaborative Group) Chemotherapy in non-small cell lung cancer: a metaanalysis using updated data on individual patient from 52 randomised clinical trials. Br Med J 1995, 311: 899-909.
3. Van Houtte P, Mornex F, Rocmans P. L'irradiation postopératoire des cancers bronchiques: la page est-elle tournée? Cancer Radiother 1999, 3: 200-202.
4. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000, 70: 358-365.
5. Mornex F, Van Houtte P, Chapet O. Locally advanced non-small cell lung cancer: the role of neoadjuvant or definitive chemoradiation dans Concomitant chemoradiation: current status and future. Mornex F, Mazeron JJ, Droz JP, Marty M (Eds). Elsevier, Paris, 1999, pp. 106-120.
6. Stephens RJ, Girling DJ, Bleehen NM, Moghissi K, Yosef HM A, Machin D. Medical Research Council Lung Cancer Working Party The role of post-operative radiotherapy in non-small-cell-lung cancer: a multicentre randomised trial in patients with staged T1-2, N1-2 M0 disease. Br J Cancer 1996, 74: 632-639.
7. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986, 315: 1377-1381.
8. Feng QF, Wang M, Wang LJ, Yang ZY, Zhang YG, Zhang DW, Yin WB. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomised trial. Int J Radiat Oncol Biol Phys 2000, 47: 925-929.
9. Dautzenberg B, Arriagada R, Chammard AR et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 1999, 86: 265-273.
10. Perez CA, Stanley K, Grundy G et al. Impact of irradiation technique and tumour extent in tumour control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the Radiation Therapy Oncology Group. Cancer 1982, 50: 1091-1099.
11. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 1999, 52: 137-148.
12. Arriagada R, Le Chevalier T, Quoix E et al. Effect of chemotherapy on locally advanced non-small lung carcinoma: a randomised study of 353 patients. Int J Radiat Oncol Biol Phys 1991, 20: 1183-1190.
13. Morita K, Fuwa N, Suzuki Y et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 1997, 42: 31-36.
14. Graham MV, Purdy JA, Emami B et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1999, 45: 323-329.
15. Rozensweig KE, Sim S, Mychalczak B, Schindelheim R, Fuks SZ, Leibel SA. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 1999, 45: 243-244.
16. Sibley GS, Maguire PD, Anscher MA, Light K, Antoine P, Marks LB. High-dose accelerated radiotherapy for non-small cell lung cancer: 7360 cGy and beyond. Int J Radiat Biol Phys 45, 1999: 241.
17. Saito M, Yokoyama A, Kurita Y et al. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: a second report. Int J Radiat Oncol Biol Phys 2000, 47: 673-680.
18. Marsiglia H, Baldeyrou P, Lartigau E et al. High-dose-rate brachytherapy as sole modality for early stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 2000, 47: 665-672.
19. Hennequin C, Tredaniel J, Chevret S et al. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis. Int J Radiat Oncol Biol Phys 1998, 42: 21-27.
20. Cox JD, Pajak TF, Asbell S et al. Interruptions of high-dose radiation therapy decrease long-term survival of favourable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 1993, 27: 493-498.
21. Sculier JP, Paesmans M, Lafitte JJ et al. A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small cell lung cancer responding to induction chemotherapy. Ann Oncol 1999, 10: 295-303
22. Dillman RO, Seagren SL, Propert KJ et al. A randomised trial of induction chemotherapy plus high-dose versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990, 323: 940-945.
23. Schaake-Koning C, van den Bogaert W, Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992, 326: 524-530.
24. Komaki R, Seiferheld W, Curran W et al. Sequential vs. concurrent chemoherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): analysis of failures in a phase III study (RTOG 9410). Int J Radiat Oncol Biol Phys 2000, 48: 113.
25. Furuse N, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999, 17: 2692-2699.
26. Vokes EE, Leopold KA, Herndon JE et al. CALGB Study 9431: a randomised phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC). Lung Cancer 2000, 29 (Suppl 1): 49.
27. Salazar OM, Creech RH. The state of the art toward defining the role of radiation therapy and the management of small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1980, 6: 1103-1117.
28. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992, 10: 890-895.
29. Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992, 327: 1618-1624.
30. Turrisi A, Kyungmann K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited samll-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999, 340: 265-271.
31. Murray N, Coy P, Pater JL et al. The importance of timing for thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. J Clin Oncol 1993, 11: 336-344.
32. Perry M, Eaton WL, Propert KJ et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987, 316: 912-918.
33. Murray N. Treatment of small cell lung cancer: the state of the art. Lung Cancer 1997, 17: S75-89.
34. Gregor A, Drings P, Postmus PE et al. Randomised trial of alternating verus sequential radiotherapy in limited-disease patients with smalll-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997, 15: 2840-2849.
35. Lebeau B, Urban T, Brechot JM et al. A randomised clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. Cancer 1999, 86: 1480-1487.
36. Nishiwaki Y, Fukuoka M, Yokoyama A et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: the Japan Clincical Oncology study. Lung Cancer 2000, 29 (Suppl 2).
37. Choi NC, Carey RW. Importance of radiation dose in achieving improved loco-regional tumour control in limited stage small-cell lung carcinoma: An update. Int J Radiat Oncol Biol Phys 1989, 17: 307-310.
38. Coy P, Hodson I, Payne DG et al. The effects of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer: initial results of a Canadian multicenter randomised trial. Int J Radiat Oncol Biol Phys 1988, 14: 219-226.
39. Arriagada R, Le Chevalier T, Borie F et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995, 87: 183-190.
40. Gregor A, Cull A, Stephens RJ et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentric randomised trial. Eur J Cancer 1997, 33: 1752-1758.
41. Auperin A, Arriagada R, Pignon JP et al. Prohylactic cranial irradiation for patients with small celllung cancer in complete remission. N Engl J Med 1999, 341: 476-484.
42. Ball D, Matthews J. Prophylactic cranial irradiation: More questions than answers. Semin Radiat Oncol 1995, 5: 61-68.
43. Medical Research Council. Randomised trial of palliative radiotherapy two-fractions vs more intensive 13-fractions radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol 1996, 8: 167-175.
44. Steenland E, Leer J, van Houwelingen H et al. The effect of a single fraction compared to multiple fractions on painful bone metastasies: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999, 52: 101-109.